Clinical validation of a house dust mite environmental challenge chamber model.

[1]  N. Krug,et al.  Safety, efficacy and repeatability of a novel house dust mite allergen challenge technique in the Fraunhofer allergen challenge chamber , 2016, Allergy.

[2]  A. Ellis,et al.  Controlled Allergen Challenge Facilities and Their Unique Contributions to Allergic Rhinitis Research , 2015, Current Allergy and Asthma Reports.

[3]  D. Bernstein,et al.  Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber. , 2015, The Journal of allergy and clinical immunology.

[4]  S. Vieths,et al.  Environmental exposure chambers in allergen immunotherapy trials: Current status and clinical validation needs. , 2015, The Journal of allergy and clinical immunology.

[5]  J. Bousquet,et al.  Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. , 2014, Allergy.

[6]  T. Brüning,et al.  Domestic Mite Antigens in Floor and Airborne Dust at Workplaces in Comparison to Living Areas: A New Immunoassay to Assess Personal Airborne Allergen Exposure , 2012, PloS one.

[7]  M. Rose,et al.  Airway responses and inflammation in subjects with asthma after four days of repeated high-single-dose allergen challenge , 2012, Respiratory Research.

[8]  T. Holland-Letz,et al.  Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  G. Viegi,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.

[10]  A. Casset,et al.  Bronchial challenge test in asthmatics sensitized to mites: role of particle size in bronchial response. , 2007, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[11]  F. Horak,et al.  A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit – the Vienna Challenge Chamber (VCC) , 2004, Current medical research and opinion.

[12]  R. Valenta,et al.  Recombinant Carp Parvalbumin, the Major Cross-Reactive Fish Allergen: A Tool for Diagnosis and Therapy of Fish Allergy1 , 2002, The Journal of Immunology.